Chloroquine’s EUA, new FDA coronavirus treatment accelerator, No Penalties for Zolgensma

Citeline Podcasts

English - April 03, 2020 15:42 - 27 minutes - 24.9 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: CDER’s Woodcock Talks About The Impact Of COVID-19

Next Episode: Device Week, April 3, 2020 – New Telemonitoring Patch; Medtronic Delays Renal Denervation Approval

Pink Sheet reporters and editors discuss the lingering questions surrounding the emergency use authorization of chloroquine and the FDA’s new program to speed therapeutic development for coronavirus, as well as break down the agency decision to not sanction Novartis over its Zolgensma data integrity problems.